Ascentage Pharma Group International American Depository Shares

IPO

Ascentage Pharma Group International American Depository Shares is a biotech company in Suzhou, China, founded in 2009. It has 3 recorded funding rounds, most recently a Corporate Round in June 2024.

A Leader in the Discovery and Development of First- and Best-in-class Small Molecule Cancer Therapies -

Headquarters
Suzhou
Employees
201–500
Founded
2009
Business Model
B2B
Last Round
Corporate RoundJun 2024
Rounds
3
Type
Public

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Global integrated biopharmaceutical company discovering, developing, and commercializing first- and best-in-class therapies for unmet medical needs.

Summary

It lists 201–500 employees. Its most recent funding was a Corporate Round in Jun 2024. Investors include Takeda (JP), Future Industry Investment Fund and Oriza Seed Fund.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOJan 2025

Sign up to see all 5 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ascentage Pharma Group International American Depository Shares on Indexed.vc
<a href="https://indexed.vc/companies/ascentage-pharma-group-international-american-depository-shares"><img src="https://indexed.vc/api/badge/company/ascentage-pharma-group-international-american-depository-shares" alt="Ascentage Pharma Group International American Depository Shares on Indexed.vc" width="260" height="76" /></a>